Gilead Sciences GILD
NASDAQ GILD
$153.57 -2.94 (-1.88%)
At close: Oct 21, 2026 · 4:00 PM EDT

Gilead Sciences (GILD) Short-Term Debt repayments (2009 - 2012)

Updated

Gilead Sciences (GILD) recorded Short-Term Debt repayments of -$650 million in Q3 2012.

Analysis

Gilead Sciences (GILD) Short-Term Debt repayments (2009 - 2012) Analysis & Trends

On a TTM basis, Gilead Sciences' Short-Term Debt repayments came in at $50 million as of Sep 30, 2012; for FY2010, it came in at $500 million, up 25.0% from FY2009.

  • Across earlier years, Short-Term Debt repayments came in at $400 million in FY2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ST Debt Repayment (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 6.45 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Vertex Pharmaceuticals 133.33 Bn 105.34 Bn 2.84 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2012 -650.00 Mn
Jun 30, 2012 350.00 Mn
Mar 31, 2012 350.00 Mn
Dec 31, 2009 200.00 Mn
API Access

Gilead Sciences Short-Term Debt repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt-repayments&ticker=GILD&period=max&api_key=YOUR_API_KEY